LOTT

Adrealm aims to rebuild the digital advertising ecosystem and cultivate a self-sustaining open ecosystem for all participants to achieve advertising efficiency. Built on ERC-20 standard of the Ethereum platform, Adrealm connects advertisers, service providers, content publishers, developers etc on its decentralized public ledger ensuring privacy and no third-party management of data. Thanks to its three-tier architecture made of an on-chain layer, off-chain layer, and a service layer, speed and efficiency can be guaranteed and the industry pain-points such as fraud, low-quality ads, and data leakage can be overcome. Adrealm relies on a particular consensus mechanism called Proof of Valid Traffic (PoVT) that makes high-quality ads and traffic the fundamental criteria for the operational success of transactions.

Cryptelo is a blockchain-based encryption technology company that provides data transfer, collaboration, versioning, and storage services. Cryptelo Platform technology combines encryption and blockchain based key management that allows for data mirroring. This means users can share data by giving access, without it ever leaving their hands, and no third party can access and read data without permission.

KardiaChain is the blockchain of blockchains. A scalable and interoperable blockchain platform for decentralized applications. Our Vision: We believe Blockchain can create equal opportunities for people, a world where people have access to opportunity to invest, to start a business, to work and to be socially mobile. Our technology empowers mass adoption, expand use-cases and lay foundation of the blockchain ecosystem. We are building a blockchain platform for decentralised applications helping to create a blockchain ecosystem that allows for scaling and connecting disparate blockchains. Our Core Technology is: - Dual Node - Elastic Sharding With Incentive Mechanism (ESWIM) - Kardia Smart Contract Markup Language (KSML) Our Use cases are: - Supply Chain Management - Fully Decentralised Cross-chain Exchange - Smart City

ICO HeadStart™ is the safest ICO fundraising platform in the world. Our experienced team of compliance experts award only carefully selected ICOs with a seal of approval after screening before these ICOs get listed on the ICO HeadStart™ platform adhering to give our community access to the best possible ICO proposals and the highest security standards in the ecosystem. In return for ETH and BTC the community receives MOAT along with voting points. Through voting the community decides which of these ICOs get funded. Elected projects receive their funds through Escrow 2.0 after the smart contract conditions have been met. ICO HeadStart's profits will be shared for 100%: 80% will be used to exchange back MOAT from the community and 20% will be used to give funded ICOs a head start. Decentralized, transparant, simple, honest.

TruePlay is a B2B platform with a complex of software solutions for online gambling business. TruePlay is not a gambling-provider, casino operator or casino owner. TruePlay allows only licensed gambling companies to access to their software (Software-as-a-service). The team are aimed at developing online gambling and making it as legal and transparent as possible from any point of view, TruePlay team has strong partners and has more than 10 years’ experience in the gambling industry.Join TruePlay and take part in the development of the gambling industry.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.